Protein, S.A. de C.V. is the Mexican pharmaceutical entity of Apotex, a Canadian-based global health company and Canada's largest pharmaceutical company. The company manufactures and distributes generic and branded medicines, operating in the pharmaceutical and medicine manufacturing industry in Mexico. It is headquartered at Damas No. 120, San Jose Insurgentes, Benito Juarez, Mexico City. As part of Apotex's Latin America operations, which span over 29 years and employ more than 900 people across the region, it works with healthcare providers and governments to improve access to affordable, high-quality medicines.
| Import | Export |
|---|---|
|
Trade Records
237
|
Trade Records
151
|
|
Suppliers
5
|
Buyers
5
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, PROTEIN S.A. DE C.V. exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the PROTEIN S.A. DE C.V. distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, PROTEIN S.A. DE C.V. sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore PROTEIN S.A. DE C.V.'s import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| APOTEX INC | PROTEIN S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| HEALTHTECH BIO ACTIVES S.L.U | PROTEIN S.A. DE C.V. | 2938 | 24 | $186,500 | 3,420 | Los Angeles |
| AA PHARMA INC. | PROTEIN S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| FETTE COMPACTING GMBH MR. KAI SCHAUMBURG | PROTEIN S.A. DE C.V. | 8207 | 24 | $186,500 | 3,420 | Los Angeles |
| CHEMO S A LUGANO BRANCH | PROTEIN S.A. DE C.V. | 2939 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into PROTEIN S.A. DE C.V.'s export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| APOTEX COSTA RICA S.A. | PROTEIN S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| APOTEX NICARAGUA, S.A. | PROTEIN S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| APOTEX PANAMA S.A. | PROTEIN S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| APOTEX PANAMA | PROTEIN S.A. DE C.V. | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| APOTEX INC | PROTEIN S.A. DE C.V. | 2925 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore PROTEIN S.A. DE C.V.'s trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access PROTEIN S.A. DE C.V.'s key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.